Early Stage Development - Integrated Programs

Early Stage Development - Integrated Programs

Products
Early Stage Development - Integrated Programs
Early Stage Development - Integrated Programs

Information

Accelerating molecules through to proof-of-concept - Simplify early development and accelerate to Proof-of Concept.Proof-of-concept (POC) is a key milestone in the development of a new drug candidate. We understand the transition to POC needs to be fast and cost-effective.With fully integrated capabilities from first-in-human testing to seamless drug product supply for patient trials, we simplify early development and accelerate molecules through to POC.
Product Categories
  • Innovative APIs
    • Other APIs
    Distribution Areas
    North America (USA, Canada)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
    Supplied From
    United KingdomUnited States
    Quotient SciencesQuotient Sciences brings 35+ years of trusted scientific insight, quality, and control to drug development with a mission to help our customers bring new molecules to patients faster. We provide a full range of drug product (CDMO) and clinical (CRO) services, which can be tightly integrated with Translational Pharmaceutics(R)—a disruptive platform to enable greater efficiency, better outcomes, and reduced timelines in development.

    Log in

    See all the content and easy-to-use features by logging in or registering!